Stem, Inc. filings document the company’s clean energy software business, public-company governance and capital structure. Results-related 8-K reports furnish quarterly and annual operating updates, including software, services and edge hardware revenue, PowerTrack software activity, adjusted EBITDA measures and management guidance.
Other filings cover proxy matters, director elections, executive compensation, board and officer changes, independent auditor changes, an at-the-market common stock offering program, Regulation FD materials and securities-litigation status. These disclosures record governance controls, stockholder voting matters, common stock issuance capacity, risk-related events and formal updates tied to Stem’s energy storage and renewable asset software operations.
Stem, Inc. reported that it is not in compliance with NYSE continued-listing standards requiring average market capitalization of at least $50.0 million over a consecutive 30 trading-day period and stockholders’ equity of at least $50.0 million. The NYSE sent a non-compliance letter on October 20, 2026.
Stem intends to submit a business plan within 45 days of receiving the letter, describing how it expects to regain compliance within 18 months. The plan must include quarterly milestones. Stem’s common stock may continue trading on the NYSE during the cure period, subject to NYSE acceptance of the plan, quarterly review, and compliance with other listing requirements. Stem said the non-compliance does not affect its operations, SEC reporting requirements, or obligations under debt or other agreements.
STEM, Inc. President, Managed Services Michael James Carlson reported that 305 restricted stock units vested on September 26, 2026, converting into 305 common shares; the common-stock transaction is reported at $4.48 per share. On September 29, 2026, he reported a sale of 146 shares at $4.67 per share to cover tax liability tied to the vesting. The footnote says the sale was automatic and not discretionary; no Rule 10b5-1 plan is reported.
STEM, Inc. officer Michael James Carlson reported a proposed sale of 146 common shares, with an aggregate market value of $671.03 and an approximate sale date of September 29, 2026. The shares are listed as restricted stock vesting on September 25, 2026; the notice says the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award. It also reports prior sales of 1,347 shares on July 2, 2,548 shares on July 29, and 3,673 shares on August 10, 2026. The notice was signed by Joshua Schmitt, a duly authorized representative of Fidelity Brokerage Services LLC and attorney-in-fact for Michael Carlson.
Stem, Inc. reported Q2 2026 revenue of $33.7 million, down from $38.4 million a year earlier, with first-half 2026 revenue of $62.7 million versus $70.9 million. PowerTrack software and edge hardware grew year over year, while managed services and battery hardware resale declined.
Gross profit in Q2 improved slightly to $13.9 million, and loss from operations narrowed to $7.7 million from $13.3 million, helped by lower research and development and general and administrative expenses. However, the company posted a Q2 net loss of $14.4 million, compared with prior-year net income that had been boosted by a large debt extinguishment gain.
Stem ended June 30, 2026 with $38.4 million in cash and cash equivalents and negative working capital of $18.2 million, alongside substantial debt, including $118.7 million of 2030 convertible notes and $160.0 million of senior secured notes. Management states that existing cash is sufficient for at least 12 months but may seek additional equity or debt financing. Remaining performance obligations totaled $366.6 million, with about 22% expected to be recognized as revenue within 12 months.
Stem, Inc. reported second quarter 2026 revenue of $33.7 million, down 12% from $38.4 million a year earlier as battery hardware resales and managed services declined. Revenue from software, services, and edge hardware was $33.4 million, up 1% year-over-year, supported by 11% growth in PowerTrack software revenue.
GAAP gross profit rose to $13.9 million with gross margin improving to 41% from 33%, while non-GAAP gross margin increased to 55% from 49%. The company posted a net loss of $14.4 million versus prior-year net income of $202.5 million, which had included a one-time gain on extinguishment of debt. Adjusted EBITDA was $6.2 million, up 63% from $3.8 million, marking a fifth consecutive quarter of positive adjusted EBITDA. Operating cash flow was $0.3 million versus a $(21.3) million outflow in the prior year quarter, and cash and cash equivalents ended at $38.4 million, slightly above $36.6 million at the end of 1Q26.
Bookings were $36.8 million, up 39% sequentially, and contracted backlog reached $27.1 million, up 18% from 1Q26. ARR rose to $62.4 million and CARR to $69.0 million, with growth in PowerTrack ARR and both solar and storage assets under management. Stem highlighted new international PowerTrack EMS projects, an industry award, the launch of its AIONA AI services offering, and reaffirmed full-year 2026 guidance, including revenue of $140–$190 million, non-GAAP gross margin of 40–50%, and adjusted EBITDA of $10–$15 million.
STEM, INC. director David S. Buzby reported the vesting and conversion of 7,486 Restricted Stock Units into an equal number of shares of common stock on August 7, 2026. The RSUs had been granted on June 4, 2025 and vested 100% on that date. Following this exercise-and-conversion, he holds 7,486 shares of common stock directly, plus 38,745 shares indirectly through the 2016 David S. Buzby Revocable Trust and 4,815 shares indirectly through the David Buzby Roth IRA.
Stem, Inc. director Krishna Shivram reported the vesting and exercise of a prior equity award. On August 7, 2026, 7,486 Restricted Stock Units (RSUs) converted into an equal number of shares of common stock on a one-for-one basis. These RSUs were originally granted on June 4, 2025 and vested 100% on August 7, 2026. Following the conversion, Krishna Shivram directly held 10,597 shares of common stock.
STEM, INC. director Adam Daley reported the vesting and conversion of 7,486 Restricted Stock Units into an equal number of common shares on August 7, 2026; these RSUs were granted on June 4, 2025 and vested 100% on that date. Following the conversion, Daley directly holds 19,535 common shares and indirectly holds 4,812 shares through the Daley Investment Trust and 4,638 shares through the Daley Revocable Trust.
Stem, Inc. director Anil Tammineedi exercised previously granted equity awards. On August 7, 2026, 7,486 restricted stock units converted on a one-for-one basis into common stock, increasing his direct common stock holdings to 15,473 shares. He also has 214,492 shares of common stock held indirectly through Angeleno Investors III, L.P., with which he may be deemed to share voting and investment power. The RSUs were originally granted on June 4, 2025, and vested 100% on August 7, 2026.
STEM, INC. director Guruswamy Vasudevan reported the vesting and conversion of 7,486 Restricted Stock Units into an equal number of shares of common stock on August 7, 2026. Each RSU converted into one share. After this exercise, Vasudevan directly owns 10,597 shares of common stock.